We have significant capabilities in molecular biology, including nucleic acid vaccine design, immunology, and tumor mouse modeling. In the past 5 years, we have nearly tripled our research team to include deeper oncology expertise, including vaccinology, even neoantigen vaccine specialization. We now have a well-defined process to take things from ideation to in vivo animal proof of concept studies before handing them off to product development.
